Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 204-263-4 | CAS number: 118-60-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- June 7 to June 27, 1989
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: guideline test with GLP, but only 1000 instead of 2000 erythrocytes were evaluated
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 989
- Report date:
- 1989
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- not specified
- GLP compliance:
- yes
- Remarks:
- Quality Assurance certificate as pre-GLP study
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- 2-ethylhexyl salicylate
- EC Number:
- 204-263-4
- EC Name:
- 2-ethylhexyl salicylate
- Cas Number:
- 118-60-5
- Molecular formula:
- C15H22O3
- IUPAC Name:
- p-menth-1-en-8-ol
Constituent 1
Test animals
- Species:
- mouse
- Strain:
- NMRI
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- Animals and Animal Management
Adult male and female NMRI mice, 25-30 g in weight and 6-10 weeks old were obtained from SAVO GmbH, D-7964 Kisslegg F.R.G.
The animals were acclimatized for at least 5 days before use in the test. They were examined for signs of disease. Animals suspected of being diseased were culled from the study and by others. The animals were separated according to sex, marked for identification, and allocated by randomization to cages and groups.
The animals were group housed up to five per cage in MAKROLON cages of size II with ALTROMIN woodshaving. The air-conditioned surrounding had a temperature of 22 ± 2 °C and a relative humidity of ca. 55 %.
Artificial light was provided in a 12/12 h light/dark cycle. The animals were given standard laboratory diet and tap-water ad libitum. The cages and beddings were changed with clean ones twice a week.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- arachis oil
- Details on exposure:
- Three groups, each comprising 5 males and 5 females, were treated with the test compound dissolved in arachis oil (5 animals per sex and term). A dose volume of 10 ml/kg body weight was given to the mice by oral intubation using a stainless steel ravage tube.
- Duration of treatment / exposure:
- 72 hours
- Frequency of treatment:
- once
- Post exposure period:
- 24, 48, 72 hours after dosing
Doses / concentrations
- Remarks:
- Doses / Concentrations:
2000 mg/kg
Basis:
nominal conc.
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- 50 mg/kg body weight 9,10-Dimethyl-X,2-benzanthracene (lot 116C-0271, Sigma chemical company, St. Louis, U.S.A., dissolved in olive oil.)
Examinations
- Tissues and cell types examined:
- The animals were dosed once at 0 h. Sampling was performed at 24 h, 48 h, and 72 h. The vehicle control group comprised 5 males and 5 females and was treated with 10 ml of arachis oil per kg body weight. Preparations were made at 24 hours. One positive control group was treated with 9,10-dimethyl-l1,2-benzanthracene (DMBA) per os. DMBA was dissolved in olive oil, A dose volume of 10 ml/kg was used in this group. Preparations from the DMBA group were made at 48 h.
- Details of tissue and slide preparation:
- Preparation of Bone Marrow Smears
The animals were killed by cervical dislocation. Bone marrow was removed from both femora by rinsing: with fetal calf serum. Bone marrow cells were centrifuged at 150 s for 10 min. and the supernatant was discarded. From the pellet, smears were made on slides and air dried, according to hematological routine. Two slides were made per animal.
The preparations were stained by the May-Gruenwald-Giemsa method according to Schmid (1973):
- Stain for 3 minutes in undiluted May-Gruenwald solution.
- Stain for 2 minutes in May-Gruenwaldt diluted with distilled water 1:1
- Rinse briefly in distilled water.
- Stain for 10 minutes in Giemsa, diluted with distilled water 1:6 -Rinse thoroughly in distilled water.
- Dry in air, clean the back side of the slides with methanol
-Clear in Xylene for 5 minutes, and mount in Eukitt, Analysis
The slides were coded and observed blindly under a microscope with a lOOx oil immersion objective lens at 1250 fold magnification. At least 1000 polychromatic erythrocytes per animal were scored for the incidence of micronuclei. The number of micronucleated normo-chromatic erythrocytes was also recorded. The ratio of polychromatic to normochromatic erythrocytes was determined for each animal by counting a total of 1000 erythrocytes. - Evaluation criteria:
- no data
- Statistics:
- Statistical significance was determined according to the methods of Kasienbaum and Bowman (1970).
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not examined
- Positive controls validity:
- valid
- Additional information on results:
- After dosing, the animals of all groups treated with the test substance showed reduced mobility. In the animals of all groups the ratio of polychromatic to normochromatic erythrocytes was normal,
In none of the different treatment times studied did HR 89/131494 produce any increase in the frequency of micronucleated polychromatic erythrocytes. Both negative and positive control frequencies of micronucleated polychromatic erythrocytes agreed with those previously- established in our laboratory and with previous reports. The incidence of micronucleated normochromatic erythrocytes over all treatment was within the expected level.
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results (migrated information): negative
It is concluded that test substance did not induce chromosomal damage or damage to the mitotic apparatus in bone marrow cells of mice. - Executive summary:
The study was performed to investigate the mutagenic effect of the compound by means of the micronucleus test in the bone marrow cells of NMRI mice.
Male and female mice were treated with one oral administration of the test substance in arachis oil at a dose level of 2000 mg/ kg body. Bone marrow mears were prepared at 24, 48, and 72 hours after treatment. Each group comprised 5 males and 5 females, as well as control groups. At least 1000 polychromatic erythrocytes per animal were scored for the incidence of micronuclei. The number of micronucleated normochromatic erythrocytes was also recorded. The ratio of polychromatic to normochromatic erythrocytes was determined for each animal by counting a total of 1000 erythrocytes.Under the test conditions described, the test compound failed to induce an increase in the incidence of micronucleated polychromatic erythrocytes compared with the negative controls at any time tested. The positive control substance, 9,10-dimethyl-1,2-benzanthracene, however, produced a huge increase in the frequency of micronucleated polychromatic erythrocytes.
Based on the available data, test article cannot cause chromosome damage in the vivo micronucleus test in mice.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
